The aforementioned studies suggest that dyslipidemia may contribute to anxiety, possibly due to the promotion of brain-derived neurotrophic factor (BDNF) production in salivary glands by hypertriglyceridemia, thereby increasing plasma BDNF content. This evidence concerns the gene BDNF and metabolic syndrome.